Template:Primary hyperaldosteronism: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" |- | colspan="1" style="text-align:center; background:DarkGray" | '''C...") |
No edit summary |
||
(9 intermediate revisions by 4 users not shown) | |||
Line 3: | Line 3: | ||
| colspan="1" style="text-align:center; background:DarkGray" | | | colspan="1" style="text-align:center; background:DarkGray" | | ||
''' | '''Primary hyperaldosteronism Microchapters | ||
''' | ''' | ||
|- bgcolor="LightGrey" | |- bgcolor="LightGrey" | ||
Line 10: | Line 10: | ||
|- bgcolor="LightCoral" | |- bgcolor="LightCoral" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism|Home]] | ||
|- | |- | ||
! | ! | ||
Line 16: | Line 16: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism Patient Information|Patient Information]] | ||
|- | |- | ||
! | ! | ||
Line 22: | Line 22: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism overview|Overview]] | ||
|- | |- | ||
! | ! | ||
Line 28: | Line 28: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism historical perspective|Historical Perspective]] | ||
|- | |- | ||
! | ! | ||
Line 34: | Line 34: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism classification|Classification]] | ||
|- | |- | ||
! | ! | ||
Line 40: | Line 40: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism pathophysiology|Pathophysiology]] | ||
|- | |- | ||
! | ! | ||
Line 46: | Line 46: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism causes|Causes]] | ||
|- | |- | ||
! | ! | ||
Line 52: | Line 52: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism differential diagnosis|Differentiating Primary Hyperaldosteronism from other Diseases]] | ||
|- | |- | ||
! | ! | ||
Line 58: | Line 58: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
Line 64: | Line 64: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism Risk Factors|Risk Factors]] | ||
|- | |- | ||
! | ! | ||
Line 70: | Line 70: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism Screening|Screening]] | ||
|- | |- | ||
! | ! | ||
Line 76: | Line 76: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism natural history, complications and prognosis|Natural History, Complications and Prognosis]] | ||
|- | |- | ||
! | ! | ||
Line 88: | Line 88: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism Diagnostic study of choice|Diagnostic study of choice]] | ||
|- | |- | ||
! | ! | ||
Line 94: | Line 94: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism history and symptoms|History and Symptoms]] | ||
|- | |- | ||
! | ! | ||
Line 100: | Line 100: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism physical examination|Physical Examination]] | ||
|- | |- | ||
! | ! | ||
Line 106: | Line 106: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism laboratory findings|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
Line 112: | Line 112: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism CT scan Findings|CT scan Findings]] | ||
|- | |- | ||
! | ! | ||
Line 118: | Line 118: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism MRI Findings|MRI Findings]] | ||
|- | |- | ||
! | ! | ||
Line 124: | Line 124: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism other imaging findings|Other Imaging Findings]] | ||
|- | |- | ||
! | ! | ||
Line 130: | Line 130: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism other diagnostic studies|Other Diagnostic Studies]] | ||
|- | |- | ||
! | ! | ||
Line 154: | Line 142: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism medical therapy|Medical Therapy]] | ||
|- | |- | ||
! | ! | ||
Line 160: | Line 148: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism surgery|Surgery]] | ||
|- | |- | ||
! | ! | ||
Line 166: | Line 154: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism Primary Prevention|Primary Prevention]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism Secondary Prevention|Secondary Prevention]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | ||
|- | |- | ||
! | ! | ||
Line 196: | Line 178: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Primary hyperaldosteronism case study one|Case #1]] | ||
|- | |- | ||
! | ! |
Latest revision as of 16:37, 6 November 2017
Primary hyperaldosteronism Microchapters |
Differentiating Primary Hyperaldosteronism from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Primary hyperaldosteronism On the Web |
American Roentgen Ray Society Images of Primary hyperaldosteronism |
Risk calculators and risk factors for Primary hyperaldosteronism |